Our Core Competencies and Capabilities
GCAT's internal capabilities encompass finance, business development, preclinical development, clinical development, human resources development, and global commercial and regulatory approval. We combine the professionalism of a US based group of medical and pharmaceutical industry leaders with the expertise of highly experienced local Chinese professionals. Our capability includes, but is not limited to:
- Providing western pharmaceutical and biotechnology companies with an efficient and cost effective way to bring proprietary products to the Chinese market
- Unique core competencies in the areas of sales and marketing, licensing and acquisitions, regulatory and clinical development in China
- Access to top Chinese GLP pre-clinical sites and GCP clinical trial sites
- Access to a team of professionals with a proven track record conducting clinical trials and bringing products to the Chinese market
- Comprehensive system to protect IP in China and create a multi-layered product protection strategy
- Extensive resources to gain access to government agencies, medical community, academic and industry networks.
- Access to a national sales network with the capability of reaching broad patient populations.
